Unknown

Dataset Information

0

Endogenous programmed death ligand-1 restrains the development and onset of Sj?gren's syndrome in non-obese diabetic mice.


ABSTRACT: Programmed death-ligand 1 (PD-L1) down-modulates various immune responses by engaging the co-inhibitory receptor programmed death-1. Expression of PD-L1 and programmed death-1 is elevated in the salivary glands of patients with Sjögren's syndrome (SS). The objective of this study is to define the role of endogenous PD-L1 in SS pathogenesis in non-obese diabetic (NOD) mouse model of this disease. We inhibited endogenous PD-L1 function by intraperitoneal administration of a blocking antibody to 6 week-old female NOD/ShiLtJ mice repeatedly during a 9-day period. PD-L1 blockade accelerated leukocyte infiltration and caspase-3 activation in the submandibular gland (SMG), production of antinuclear and anti-M3 muscarinic acetylcholine receptor (M3R) autoantibodies and impairment of saliva secretion, indicative of accelerated development and onset of SS. The effect of PD-L1 blockade was associated with increased T- and B cells and T helper 1 cytokine IFN-? in the SMG. Local administration of exogenous IFN-? to the SMG led to impaired salivary secretion accompanied by down-regulation of aquaporin 5 and an increase in anti-M3R autoantibodies. Conversely, neutralization of IFN-? markedly improved salivary secretion and aquaporin 5 expression in anti-PD-L1-treated NOD/ShiLtJ mice. Hence, endogenous PD-L1 hinders the development and onset of SS in NOD mice, in part by suppressing IFN-? production.

SUBMITTER: Zhou J 

PROVIDER: S-EPMC5155421 | BioStudies | 2016-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4841619 | BioStudies
2015-01-01 | S-EPMC4395994 | BioStudies
2016-01-01 | S-EPMC4780410 | BioStudies
1000-01-01 | S-EPMC5376226 | BioStudies
1000-01-01 | S-EPMC5974126 | BioStudies
2020-01-01 | S-EPMC7058624 | BioStudies
1000-01-01 | S-EPMC1798026 | BioStudies
2020-01-01 | S-EPMC7133737 | BioStudies
2013-01-01 | S-EPMC3729733 | BioStudies
2020-01-01 | S-EPMC7764018 | BioStudies